Guidelines for prevention of NSAID-related ulcer complications. - Wikidata - awgldk - TriplyDB

Guidelines for prevention of NSAID-related ulcer complications.

Guidelines for prevention of NSAID-related ulcer complications.

http://www.wikidata.org/entity/Q33412100

about

Use of NSAIDs in treating patients with arthritis A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity Non-Steroidal Anti-Inflammatory Drugs and Aspirin Therapy for the Treatment of Acute and Recurrent Idiopathic Pericarditis NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species Current perspectives in NSAID-induced gastropathy Cardiovascular risk with non-steroidal anti-inflammatory drugs: clinical implications Piroxicam-β-cyclodextrin: a GI safer piroxicam Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment Trends in long-term opioid prescribing in primary care patients with musculoskeletal conditions: an observational database study.25 Years of Proton Pump Inhibitors: A Comprehensive Review.Impact of EHR-based clinical decision support on adherence to guidelines for patients on NSAIDs: a randomized controlled trial Systematic review with meta-analysis: the gastrointestinal benefits of COX-2 selective inhibitors with concomitant use of low-dose aspirin.The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage.Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the Osteoarthritis Initiative.Interobserver variation in the endoscopic diagnosis of gastroduodenal ulcer scars: implications for clinical management of NSAIDs users.Contemporary Diagnostic Strategies for the Detection of Helicobacter pylori Infection Practice guidelines for pharmacists: The management of osteoarthritis.Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.A Retrospective Study to Assess the Effect of Proton Pump Inhibitors on Renal Profile in a South Indian Hospital.Ischaemic cardiovascular risk and prescription of non-steroidal anti-inflammatory drugs for musculoskeletal complaints.Bacterial load and cytokine profile in patients with cirrhosis following therapy with proton pump inhibitors: a prospective cohort study.Adverse effects of long-term proton pump inhibitor therapy.Use of proton pump inhibitors after antireflux surgery: a nationwide register-based follow-up study.Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers Appropriateness of treatment recommendations for PPI in hospital discharge letters.Gastroprotective agent underuse in high-risk older daily nonsteroidal anti-inflammatory drug users over time Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis.Proton pump inhibitor use in the U.S. ambulatory setting, 2002-2009 Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and meta-analysis.Development and validation of a sensitive and high-throughput LC-MS/MS method for the simultaneous determination of esomeprazole and naproxen in human plasma.Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs.Proton pump inhibitors: Are we still prescribing them without valid indications?Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights Inappropriate use of proton pump inhibitors in a local setting The role of aspirin in the prevention of cardiovascular disease.Recognizing the Risks of Chronic Nonsteroidal Anti-Inflammatory Drug Use in Older Adults.Helicobacter pylori infection in bleeding peptic ulcer patients after non-steroidal antiinflammatory drug consumption.Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: results from a population-based survey in olmsted county, Minnesota.

P2860

Q21195252-A62C4FE2-0ECD-4DC8-8DEE-E8335A79AD16 Q24615651-F2E837DE-BE05-45CF-9AB0-3CA7A96B0520 Q26749687-2AAB7F18-9A41-4CBA-B74E-F2E1015729C1 Q26784322-678E3016-28A4-45C9-A630-7C1B8C869E2F Q26827673-0792F1C3-8C3A-4391-BCF2-6ADB124698F8 Q27002539-323212FD-5E46-47FE-8BCE-245F1CCA7451 Q27023475-F3AB1815-4222-45EC-8CEE-E749023B04B4 Q27026351-DF8F5659-11F4-4DB0-B553-F4AA4579094E Q27027977-2E02229F-864F-404C-9FB5-5BD07FF5D90D Q27316260-349120EC-93B3-489F-ACE6-862FEEF8FACF Q28070003-C7B9543B-E9CA-46B7-81FD-E1427BE0C4DB Q28385750-B9E4F5C9-097D-4AEB-99D9-BFFCFEA74330 Q30248439-1BA1E951-5428-4C72-B4AC-C9C8EE6B3069 Q30415171-ED0C1645-6C35-4BD3-8ACB-EB5B9D7BC840 Q30629677-5F9F9A07-5932-483E-B43F-B44C6C2B693B Q30665172-DCE82431-A334-4255-8825-551013CA4E85 Q31034785-309DED93-A04B-4C3F-8901-091BBE4F25F0 Q33624655-85813D21-4BF7-4C75-87A2-E0A681A17EF9 Q33632527-B1CDC4C2-CF59-4F26-8F3D-A632CA7D28BC Q33675495-DC8FBB3D-DDBD-4AF0-B6FC-185A5FAA2F37 Q33741655-56047098-2667-47B0-9491-3DBAA113A682 Q33821026-DAAC0021-CED0-4D5C-A8F1-E6BCAE7DE412 Q33822986-E942D7E2-FFEE-4C54-98E8-E94C7C511058 Q34167899-B75D791F-2E7C-494E-9EC6-67491AC28B87 Q34237263-853733C3-F966-4BA3-8111-D0544103B572 Q34241978-8D1F202C-DB46-4DB8-88CC-53F2B5C2CAAA Q34316620-5A639208-1246-4327-84F3-3CB3BC952D62 Q34389027-6BA31E99-9F61-41EC-8EC3-C7A32542ED9F Q34499039-3601310A-6EA4-4CA1-AF33-C7DCD5CCBA87 Q34589801-C3095A8B-FA60-4625-B771-79E7AC809E08 Q34606022-CDC09F0F-FBBE-4263-9410-CB9C09D1C57E Q34618109-39AC112F-90CB-41FD-B3CA-6E38B387A0DD Q34636475-A5D3E2B2-BA2A-4624-993B-C25898746445 Q34652739-68E57B28-1928-41C7-BF15-1712549F74A7 Q34663572-7394ACDB-7D95-467A-BF3A-ED0081672681 Q34929084-FE692990-DE5B-4172-9F15-AF32D9FCADCA Q35049359-D58C159A-0D87-4D85-9FF5-D5ABC4190B69 Q35171694-0F1BD71B-BED4-4AEB-85BF-EA0C26B16BE8 Q35555697-4578378A-93BC-453F-A98D-F4CD557A6CD5 Q35579999-5CA76F72-07F8-48FC-B1E5-6D5BCB8E653B

P2860

Guidelines for prevention of NSAID-related ulcer complications.

http://www.wikidata.org/entity/Q33412100

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Guidelines for prevention of NSAID-related ulcer complications.

@ast

Guidelines for prevention of NSAID-related ulcer complications.

@en

type

label

Guidelines for prevention of NSAID-related ulcer complications.

@ast

Guidelines for prevention of NSAID-related ulcer complications.

@en

prefLabel

Guidelines for prevention of NSAID-related ulcer complications.

@ast

Guidelines for prevention of NSAID-related ulcer complications.

@en

P1433

Q33412100-914DF0A1-2E25-40B1-ABD7-FFC5FEEC0A86

P1476

Q33412100-E7B95BE3-1E0E-4210-9B7B-A8F5865A43C7

P2093

Q33412100-01788C8F-F68E-42CE-BBB2-5B0B58157B14

Q33412100-195C44D3-1EA1-4C5B-9F38-8AF8D3831451

Q33412100-3DE3571D-373F-4D85-9638-E59F88E9D0AB

Q33412100-EA5DE5A5-FE69-457F-A519-3E36EA4FD639

P2860

Q33412100-0D131D96-6931-4028-8A55-78CA257047FB

Q33412100-2D14E744-B309-46A8-B827-84228513867D

Q33412100-2F4367EE-4CC4-4580-B3B9-E3BC2F853269

Q33412100-2F72B670-4ECC-43DF-96AF-EB3DAF5470EA

Q33412100-3839D199-A297-42E2-ACE8-4F02146A84B8

Q33412100-53C5BD55-7F73-483C-ACE5-F1DA01735D62

Q33412100-6C31F88E-A10F-4A08-927C-CD3751576905

Q33412100-AD2BB5AF-4107-4331-A0A8-8A71F7804B83

Q33412100-C9F174F6-B286-4DFB-9A4F-4E33FACBC105

Q33412100-CCBDD092-DBBF-43EB-886A-673D4B645882

P304

Q33412100-04FEDF4C-5629-41F5-A30D-88383F8E6F7D

P31

Q33412100-70893FAA-C074-4D60-88B0-861E77C9D184

P356

Q33412100-C334699D-DF15-49A7-86D7-B9C722FBD209

P407

Q33412100-86E63E4A-93E8-4E0E-8AB0-2036685FF760

P433

Q33412100-E7E0B09A-6554-4F4A-859C-022C3CEE9E2A

P478

Q33412100-25CDD4F4-751D-4B6F-B33F-CDDD1CCDD2CD

P577

Q33412100-1B3C3B86-62D2-4488-B141-72207A4B9D1D

P5875

Q33412100-09D1B5DA-167E-4522-8BED-08E07FA8E77D

P698

Q33412100-8C295F2F-CAED-47B4-BAAE-25967B951096

P356

P1433

The American Journal of Gastroenterology

P1476

Guidelines for prevention of NSAID-related ulcer complications.

@en

P2093

Eamonn M M Quigley

http://www.w3.org/2001/XMLSchema#string

Francis K L Chan

http://www.w3.org/2001/XMLSchema#string

Frank L Lanza

http://www.w3.org/2001/XMLSchema#string

Practice Parameters Committee of the American College of Gastroenterology

http://www.w3.org/2001/XMLSchema#string

P2860

Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force

The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force

Final report on the aspirin component of the ongoing Physicians' Health Study

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial.

A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.

Nonsteroidal anti-inflammatory drugs and peptic ulcer disease.

Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons.

Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.

Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial.

P304

728-738

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/AJG.2009.115

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24038153

http://www.w3.org/2001/XMLSchema#string

P698

19240698

http://www.w3.org/2001/XMLSchema#string